Table 1.
Baseline characteristics and results of cases
| Age/sex | Body height (cm) | Actual BW (kg) | Ideal BW (kg) | DOS | Pre-IgGNC (S/C) | Post-IgGNC (S/C) | Pre-IgGSP (AU/mL) | Post-IgGSP (AU/mL) | Follow-up IgGSP (AU/mL) | |
|---|---|---|---|---|---|---|---|---|---|---|
| Case 1 | 89/M | 170 | 54.8 | 63.6 | 1 | 0.02 | 0.02 | 231.2 | 145,364.0 | 27,203.9* |
| Case 2 | 89/F | 148 | 47 | 48.2 | 3 | 0.05 | 0.04 | 2.9 | 224,535.0 | |
| Case 3 | 79/F | 159 | 57 | 55.6 | 7 | 0.02 | 0.08 | 0.9 | 222,255.0 | |
| Case 4 | 78/F | 151 | 48 | 50.2 | 6 | N/D | 0.01 | N/D | 288,938.0 | |
| Case 5 | 62/M | 192 | 135 | 81.1 | 9 | 0.03 | 0.03 | 0.01 | 128,436.0 | |
| Case 6 | 57/F | 148 | 50 | 48.2 | 3 | 0.08 | 0.16 | 25.4 | 332,710.1 | |
| Case 7 | 53/M | 171 | 71 | 64.3 | 4 | 0.02 | N/D | 6 | > 80,000.0 | |
| Case 8 | 47/M | 165 | 72 | 59.9 | 5 | 0.02 | 0.1 | 0.01 | 194,485.0 | 78,706.2** |
| Case 9 | 45/M | 178 | 103 | 69.7 | 3 | 0.04 | 0.04 | 699.9 | 179,813.0 |
*Follow-up IgG was measured 42 days after the administration of REGN-COV in Case 1
**Follow-up IgG was measured 12 days after the administration of REGN-COV in Case 8
BW body weight, DOS days after the onset of symptoms of COVID-19, S/C sample result divided by the calibrator result, AU arbitrary units